UrologiePub Date : 2025-09-01Epub Date: 2025-08-20DOI: 10.1007/s00120-025-02662-x
Axel Belusa, Peter J Goebell, Peter Kollenbach, Mira Faßbach, Peter Kühne, Sulafah El-Khadra, Thomas Quack, Mario Kramer
{"title":"[Update guideline on prostate cancer-balancing act between evidence and healthcare reality].","authors":"Axel Belusa, Peter J Goebell, Peter Kollenbach, Mira Faßbach, Peter Kühne, Sulafah El-Khadra, Thomas Quack, Mario Kramer","doi":"10.1007/s00120-025-02662-x","DOIUrl":"https://doi.org/10.1007/s00120-025-02662-x","url":null,"abstract":"<p><p>The update of the guideline on prostate cancer has been and continues to be discussed in all its facets, even with passion.One source of the dispute about some of the content of the current guideline is undoubtedly the lack of precision with which terms were introduced in the past and are still communicated incorrectly and vaguely to this day.In this article, the Professional Association of German Urology (BvDU) discusses five key points with professional policy relevance and where the implementation of the guideline meets the reality of care.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"64 9","pages":"968-972"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-09-01Epub Date: 2025-07-21DOI: 10.1007/s00120-025-02637-y
Stephan O Adler, Daniela Hery, Eduard C Groen, Jean Stadlbauer, Theresa D Ahrens
{"title":"[Digital health: a green future for healthcare?]","authors":"Stephan O Adler, Daniela Hery, Eduard C Groen, Jean Stadlbauer, Theresa D Ahrens","doi":"10.1007/s00120-025-02637-y","DOIUrl":"10.1007/s00120-025-02637-y","url":null,"abstract":"<p><p>The healthcare sector is doubly affected by the climate crisis. On the one hand, the number of disease and injury cases will increase due to various effects such as heatwaves or natural disasters, further burdening the healthcare system. On the other hand, the healthcare sector itself significantly contributes to the emissions that exacerbate the climate crisis. A seemingly unsolvable vicious circle. That is why the present article discusses the relationship between digital health and sustainability in healthcare. Digital innovations such as telemedicine, digital diagnostics, or the use of artificial intelligence can increase efficiency and thus significantly relieve the burden on medical professionals. For the advantages of these technologies to outweigh inherent disadvantages like their high energy demand, digital and sustainable transformations must be addressed simultaneously. This so-called \"twin transformation\" shows that it can even unleash synergies. Therefore, this article describes interesting technological approaches and current research topics such as digital twins of patients and their sustainable design for healthcare. In addition, examples specific to urology are presented.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"892-899"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-08-21DOI: 10.1007/s00120-025-02663-w
Julio Ruben Rodas Garzaro, Anton Kravchuk, Johannes Moersler, Stephan Siepmann, Elisabeth Stemplinger, Fabian Eder, Matthias May, Christian Gilfrich
{"title":"[Atypical contrast enhancement in mucinous prostate cancer : Limitations of the PI-RADS (Prostate Imaging Reporting and Data System) classification and implications for modern imaging].","authors":"Julio Ruben Rodas Garzaro, Anton Kravchuk, Johannes Moersler, Stephan Siepmann, Elisabeth Stemplinger, Fabian Eder, Matthias May, Christian Gilfrich","doi":"10.1007/s00120-025-02663-w","DOIUrl":"https://doi.org/10.1007/s00120-025-02663-w","url":null,"abstract":"<p><p>Mucinous prostate carcinoma (mucPCa) often evades detection by prostate-imaging reporting and data system (PI-RADS)-based multiparametric magnetic resonance imaging (MRI). We report a case in which atypical dynamic contrast kinetics served as the sole imaging clue leading to the diagnosis of aggressive mucPCa. Neither T2-weighted nor diffusion-weighted sequences suggested malignancy. Only a targeted MRI/ultrasonography (US) fusion biopsy confirmed an International Society of Urological Pathology (ISUP) grade 4 mucPCa. This case underscores the diagnostic limitations of standardized imaging protocols and highlights the critical importance of contrast enhancement in rare histological subtypes.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-08-05DOI: 10.1007/s00120-025-02665-8
Laila Schneidewind, Bernhard Kiss, Nicolas Arnold, Jennifer Kranz, Friedemann Zengerling, Annabel Spek, Thomas Neumann, Annemarie Uhlig
{"title":"[Gender-specific differences in outcome and survival in early cystectomy : Systematic review].","authors":"Laila Schneidewind, Bernhard Kiss, Nicolas Arnold, Jennifer Kranz, Friedemann Zengerling, Annabel Spek, Thomas Neumann, Annemarie Uhlig","doi":"10.1007/s00120-025-02665-8","DOIUrl":"https://doi.org/10.1007/s00120-025-02665-8","url":null,"abstract":"<p><strong>Background: </strong>Despite a lower incidence, women with bladder cancer have poorer survival rates than men. However, studies to date have provided insufficient data on gender-specific treatment outcomes, particularly after radical early cystectomy for Bacillus Calmette-Guérin (BCG) failure.</p><p><strong>Objectives: </strong>Are there gender-specific differences in oncologic outcomes and complication rates after radical early cystectomy in patients with nonmuscle invasive bladder cancer after failure of BCG instillation therapy?</p><p><strong>Materials and methods: </strong>A systematic literature search was conducted in MEDLINE and the Cochrane Library in January 2025. The complete study protocol has been prospectively registered at PROSPERO (ID CRD42024611111).</p><p><strong>Results: </strong>Three retrospective cohort studies with a total of 655 patients (18.8% of whom were women) were included. There were no significant gender-specific differences in terms of overall survival, cancer-specific survival, or progression. Data on complications and quality of life were limited or not available. In two studies, prostatic urethral involvement was identified as a negative prognostic marker in men.</p><p><strong>Conclusion: </strong>The current evidence base is sparse, methodologically limited, and biased by the underrepresentation of women. Therefore, it is not possible to make reliable statements on the effect of gender on the efficacy of early cystectomy after BCG failure. Further research on gender-dependent risk factors, especially hormonal and immunological influences, is urgently needed to develop personalized treatment strategies.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-08-01Epub Date: 2025-06-26DOI: 10.1007/s00120-025-02607-4
Christian Pfeiffer
{"title":"[Patient management in emergency and acute care: well-considered decision-making instead of actionism].","authors":"Christian Pfeiffer","doi":"10.1007/s00120-025-02607-4","DOIUrl":"10.1007/s00120-025-02607-4","url":null,"abstract":"<p><p>Emergency and acute care in Germany is at a crossroads. Without a practical strategy tailored to regional circumstances, we run the risk of destabilizing healthcare provision in Germany in the long term. The care landscape in emergency medicine is highly complex and any reform must take this interplay into account. Another current problem is the increasing shortage of staff. In recent years, Bavaria has shown what future-oriented emergency care can look like. We must reform emergency care with caution and expertise. Politicians must not be guided by short-term promises of solutions, but must focus on proven, practical concepts.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"758-761"},"PeriodicalIF":0.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-08-01Epub Date: 2025-05-19DOI: 10.1007/s00120-025-02583-9
Christian Dirscherl, Thomas Ebert, Bernd J Schmitz-Dräger, Peter J Goebell
{"title":"[PSA in the extreme range-an expression of an unfavorable prognosis? : A review of course and treatment of prostate cancer with prostate-specific antigen (PSA) values in the three-to-four-digit range].","authors":"Christian Dirscherl, Thomas Ebert, Bernd J Schmitz-Dräger, Peter J Goebell","doi":"10.1007/s00120-025-02583-9","DOIUrl":"10.1007/s00120-025-02583-9","url":null,"abstract":"<p><strong>Background: </strong>Extremely high baseline prostate-specific antigen (bPSA) values in the range of 100 to ≥ 1000 ng/ml prior to the start of systemic therapy pose a challenge, as they can lead to the impression of a very unfavorable prognosis.</p><p><strong>Objective: </strong>We investigated factors influencing 5‑year overall survival (5-yOS) and the treatment modalities of patients with bPSA levels ≥ 100 ng/ml using retrospective data.</p><p><strong>Materials and methods: </strong>We defined items from a limited initial collective, which we then used for a query in the UroCloud database. A total of 695 patients were included.</p><p><strong>Results and conclusion: </strong>For the entire collective, the 5‑yOS was 68.5% ± 2.7%. The bPSA value had a significant (p < 0.001) influence on 5‑yOS in the following groups: 100-149 ng/ml, 150-249 ng/ml, 250-649 ng/ml, and ≥ 650 ng/ml (5-yOS: 77.0% ± 4.9% vs. 76.9% ± 4.5% vs. 61.4% ± 6.0 vs. 57.4% ± 6.1%, respectively). Age ≤ 70 years compared to > 70 years at first diagnosis resulted in a significant difference regarding 5‑yOS (74.8% ± 3.5% vs. 60.1% ± 4.4, respectively). A PSA response of > 90%, which was achieved in 79.0% of cases, had a significant influence on 5‑yOS compared to a response of ≤ 90% (73.5% ± 2.9% vs. 48.6% ± 6.7%, respectively). There was also a significant 5‑yOS advantage if a first PSA nadir of ≤ 0.20 ng/ml was achieved (in 22.2%) compared to a first PSA nadir of > 0.20 ng/ml (89.8% ± 3.3% vs. 60.4% ± 3.5%, respectively). In 49.4% (n = 343) of cases, androgen deprivation therapy (ADT) monotherapy was started as first-line systemic therapy. Between 1999 and 2023, we saw an increase in escalated and initial combination therapies. The analysis shows that an extreme bPSA value is not in itself an expression of an unfavorable prognosis.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"803-814"},"PeriodicalIF":0.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-08-01Epub Date: 2025-05-31DOI: 10.1007/s00120-025-02615-4
Jens Westphal
{"title":"[Cooperation instead of competition-new approaches in urological care].","authors":"Jens Westphal","doi":"10.1007/s00120-025-02615-4","DOIUrl":"10.1007/s00120-025-02615-4","url":null,"abstract":"<p><p>Urological care in Germany is in a state of flux. New interfaces are emerging between outpatient and inpatient structures, which pose not only organizational and professional but also economic challenges. The central challenge is the increasing importance of outpatient care and its integration into everyday clinical practice and the associated cooperation between hospitals and community-based physicians, including in the context of urological training. Only through close and trusting cooperation is it possible to ensure high-quality patient care and act in an economically sensible manner. The author is particularly critical of the \"cold\" streamlining of the hospital landscape in North Rhine-Westphalia due to the increasing insolvency of hospitals. This could also jeopardize urological care in the medium and long term. Existing urological hospital structures, especially inpatient departments, have been closed, while the care of urological patients has been made considerably more difficult due to a lack of opportunities for expansion, e.g., of operating room capacities in the hospitals providing care. At the same time, the article aims to provide encouragement. The younger generation in particular is prepared to think, act and work across sectors. The author appeals to all those involved to see cooperation not as a necessary evil, but as a strategic opportunity. This is the only way that patient care can be guaranteed in the future in a comprehensive and quality-assured manner. It is not just about medical expertise, but also about structure, communication and trust between the people involved.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"762-768"},"PeriodicalIF":0.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The role of primary RPLND in clinical stage IIA/B testicular germ cell tumor: a narrative review.","authors":"Parth Thakker, Connor Drake, Timothy Masterson, Clint Cary","doi":"10.1007/s00120-025-02648-9","DOIUrl":"https://doi.org/10.1007/s00120-025-02648-9","url":null,"abstract":"<p><p>Retroperitoneal lymph node dissection (RPLND) plays a critical role in the multidisciplinary management of advanced testicular cancer. Cisplatin-based chemotherapy regimens have been the cornerstone of treatment for these patients. Long-term toxicity and secondary malignancy in patients receiving cisplatin, along with surgical advancements, have encouraged providers to revisit the role of primary RPLND for patients with stage IIA/B germ cell tumor. Nerve-sparing primary RPLND offers durable oncologic outcomes without the long-term comorbidities associated with chemotherapy. The focus of this review is to summarize the published data on primary RPLND for stage IIA/B germ cell tumors, to identify the ideal patient population for this treatment modality, and to explore the future of surgical advancements.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144761591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-08-01Epub Date: 2025-06-24DOI: 10.1007/s00120-025-02622-5
Severin Pöchtrager
{"title":"[Healthcare without boundaries: revolution in cross-sector healthcare delivery].","authors":"Severin Pöchtrager","doi":"10.1007/s00120-025-02622-5","DOIUrl":"10.1007/s00120-025-02622-5","url":null,"abstract":"<p><p>Hospital at home (HaH) is an internationally evaluated and widely established model of care in many countries. HaH is an acute clinical service that provides personnel, equipment, technology, medications, and skills that are typically available in hospitals, and delivers hospital-level care for selected individuals in their own homes or in nursing facilities. An interprofessional team consisting of nurses, therapists, and physicians treats patients-who would otherwise be cared for in a conventional hospital bed-in their own beds at home. Patients receive needs-based nursing and medical visits several times a day, and the team is available 24 h a day, 7 days a week. The average duration of treatment is similar to that of a conventional inpatient stay, ranging from 3-9 days. In current pilot projects in Switzerland, patients with internal medicine or palliative acute conditions are predominantly being treated. A Cochrane review based on 20 randomized studies on HaH shows high patient safety, lower complication rates compared to the traditional inpatient setting, lower treatment costs, and high patient satisfaction.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"769-772"},"PeriodicalIF":0.5,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144477018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}